Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6854977

C=C(C)C(=O)OC(CCCCCCCCCCCCCCCCC)[P+](C)(C)C.[Cl-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
FAAH O00519 5/20 0.42
LMNA P02545 2/20 0.39
TRPV1 Q8NER1 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
GPR84 Q9NQS5 3/20 0.37
FFAR1 O14842 1/20 0.37
CA1 P00915 1/20 0.37
ZDHHC7 Q9NXF8 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7111364 1.00 TSHR (0.53) TSHRFAAHLMNATRPV1CNR1
SCHEMBL17358266 0.90 TSHR (0.55) TSHRFAAHLMNATRPV1CNR1
SCHEMBL9305316 0.87 TSHR (0.49) TSHRFAAHLMNATRPV1CNR1
SCHEMBL27581344 0.87 TSHR (0.49) TSHRFAAHLMNATRPV1CNR1
SCHEMBL9139954 0.87 TSHR (0.49) TSHRFAAHLMNATRPV1CNR1
SCHEMBL27370522 0.86 TSHR (0.47) TSHRFAAHLMNATRPV1CNR1
Hydrochloric Acid SCHEMBL28431427 0.86 TSHR (0.51) TSHRFAAHLMNATRPV1GPR84
SCHEMBL17358268 0.85 TSHR (0.50) TSHRFAAHLMNATRPV1GPR84
SCHEMBL7916049 0.85 TSHR (0.46) TSHRFAAHLMNAGPR84FFAR1
SCHEMBL8343958 0.84 TSHR (0.45) TSHRFAAHLMNATRPV1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220266296-A1 Methods of Photografting to Surface Metal Oxides Orthobond Corporation 2022-08-25 US claimed
US-20230055449-A1 FUNCTIONAL SURFACES ORTHOBOND CORP (US) 2023-02-23 US disclosed
WO-2022182713-A1 METHODS OF PHOTOGRAFTING TO SURFACE METAL OXIDES Orthobond Corporation (US) 2022-09-01 WO disclosed
US-20220266296-A1 Methods of Photografting to Surface Metal Oxides Orthobond Corporation 2022-08-25 US disclosed
EP-3525776-B1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS ORTHOBOND CORP (US) 2022-01-26 EP disclosed
CN-110312507-B Surfaces with oligomeric or polymeric antimicrobial agents 奥索邦德公司 2021-11-23 CN disclosed
US-20210352903-A1 FUNCTIONAL SURFACES ORTHOBOND CORP (US) 2021-11-18 US disclosed
US-11154061-B2 Functional surfaces Orthobond Corporation (US) 2021-10-26 US disclosed
US-10390533-B2 Surfaces with oligomeric or polymeric antimicrobials Orthobond Corporation (US) 2019-08-27 US disclosed
EP-3525776-A1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS Orthobond Corporation (US) 2019-08-21 EP disclosed
WO-2018075457-A1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS Orthobond Corporation (US) 2018-04-26 WO disclosed
US-20180103642-A1 Surfaces with Oligomeric or Polymeric Antimicrobials Orthobond Corporation 2018-04-19 US disclosed
US-20180103643-A1 Functional Surfaces Orthobond Corporation 2018-04-19 US disclosed
US-6790877-B2 Bonding compositions for dental use KURARAY CO., LTD. (JP) 2004-09-14 US disclosed
US-6355704-B1 BACTERICIDE PRIMERS; BONDING TO TEETH KURARAY CO., LTD. (JP) 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180103642-A1 Surfaces with Oligomeric or Polymeric Antimicrobials PICALM, NONO, LPO TSHR 1455/4885FAAH 4478/4885LMNA 4563/4885
US-20230055449-A1 FUNCTIONAL SURFACES LPO, SELP, SIGLEC7 TSHR 2514/4885FAAH 3624/4885LMNA 3860/4885
US-11154061-B2 Functional surfaces LPO, SELP, SIGLEC7 TSHR 2514/4885FAAH 3624/4885LMNA 3860/4885
US-20210352903-A1 FUNCTIONAL SURFACES LPO, SELP, SIGLEC7 TSHR 2514/4885FAAH 3624/4885LMNA 3860/4885
US-10390533-B2 Surfaces with oligomeric or polymeric antimicrobials PICALM, NONO, LPO TSHR 1455/4885FAAH 4478/4885LMNA 4563/4885
US-20180103643-A1 Functional Surfaces LPO, SELP, SIGLEC7 TSHR 2514/4885FAAH 3624/4885LMNA 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.